by Robert Brodis | Apr 9, 2025 | Healthcare Quality
EMOL Health Leadership had the opportunity to attend the NCCN 2025 Annual Conference and present the results of a study on Myelosuppression and Healthcare Utilization in Community Oncology Patients with Limited-Stage Small Cell Lung Cancer (LS-SCLC) Receiving...
by Robert Brodis | Feb 27, 2025 | EMOL Partners
EMOL Health, a data aggregation company for community oncology practices, Ajeet Gajra, MD, and Pharmacosmos (G1 Therapeutics) are proud to announce that their abstract has been accepted for presentation at the 2025 NCCN Annual Conference to be held in Orlando, March...
by Robert Brodis | Oct 21, 2024 | Healthcare Quality
In October 2024, leadership from EMOL Health was able to attend the Association for Value-Based Cancer Care (AVBCC) Fall Summit, held in New York, NY. EMOL Health President & CEO, Brian Decker, was invited to participate in an important panel discussion on...
by Robert Brodis | Sep 16, 2024 | Healthcare Quality
Dr. Ray Page, DO, PhD of the Center for Cancer and Blood Disorders (Texas Cancer Center) was joined by EMOL Health Leadership the 2024 World Conference on Lung Cancer in San Diego. They jointly presented their results from a year long program that was implemented...
